Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial - The Lancet Neurology
MS charities decry UK postcode lottery for 'life-changing' drug | Multiple sclerosis | The Guardian
Late-Onset MS: Diagnosis After 50
What is AMPYRA® (dalfampridine)?
Multiple Sclerosis: Your Everyday Guide to Living Well | Everyday Health